ויפנד 200 מ"ג אבקה להזרקה

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

VORICONAZOLE 200 MG/VIAL

Disponible depuis:

PFIZER PHARMACEUTICALS ISRAEL LTD

Code ATC:

J02AC03

forme pharmaceutique:

POWDER FOR SOLUTION FOR INFUSION

Mode d'administration:

I.V

Fabriqué par:

PFIZER PGM, FRANCE

Groupe thérapeutique:

VORICONAZOLE

indications thérapeutiques:

Treatment of : - invasive aspergillosis fluconazole-resistant serious invasive Candida infections (including C. krusei), - serious fungal infections caused by scedosporium spp. and fusarium spp.Vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. Treatment of candidemia in non neutropenic patients.

Date de l'autorisation:

2012-10-01